We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.88B
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+32.38%
3 Year Est. Return
+99.93%
5 Year Est. Return
+115.9%
10 Year Est. Return
+395.26%
AUM
$807M
AUM Growth
+$40.8M
Cap. Flow
+$16.3M
Cap. Flow %
2.02%
Top 10 Hldgs %
17.11%
Holding
932
New
112
Increased
378
Reduced
301
Closed
51

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$1.34M
2
IYR icon
iShares US Real Estate ETF
IYR
+$1.18M
3
BCML icon
BayCom
BCML
+$1.11M
4
D icon
Dominion Energy
D
+$970K
5
NVDA icon
NVIDIA
NVDA
+$955K

Sector Composition

Rank Sector Weight
1 Technology 12.08%
2 Financials 10.28%
3 Healthcare 10.1%
4 Consumer Discretionary 9.01%
5 Industrials 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNTC icon
826
Benitec Biopharma
BNTC
$414M
$40K 0.01%
+78
New +$52.7K
GEVO icon
827
Gevo
GEVO
$353M
$39K ﹤0.01%
+10,336
New +$71.8K
NVAX icon
828
Novavax
NVAX
$1.21B
$39K ﹤0.01%
1,447
+15
+1% +$507
FAC
829
DELISTED
First Acceptance Corp.
FAC
$38K ﹤0.01%
+33,500
New +$28.1K
IRD
830
Opus Genetics
IRD
$287M
$36K ﹤0.01%
531
APPS icon
831
Digital Turbine
APPS
$982M
$35K ﹤0.01%
23,000
+2,000
+10% +$3.43K
TOVX icon
832
Theriva Biologics
TOVX
$10.1M
$32K ﹤0.01%
15
AXAS
833
DELISTED
Abraxas Petroleum Corp
AXAS
$31K ﹤0.01%
528
+28
+6% +$1.52K
NAT icon
834
Nordic American Tanker
NAT
$1.36B
$29K ﹤0.01%
10,836
-19,997
-65% -$44.1K
SGYP
835
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$28K ﹤0.01%
16,325
+1,925
+13% +$3.33K
NVIV
836
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$28K ﹤0.01%
22
+17
+340% +$93.3K
YOGA
837
DELISTED
YogaWorks, Inc. Common Stock
YOGA
$26K ﹤0.01%
14,179
-800
-5% -$1.71K
AGRX
838
DELISTED
Agile Therapeutics
AGRX
$25K ﹤0.01%
+25
New +$87.7K
FCEL icon
839
FuelCell Energy
FCEL
$1.45B
$23K ﹤0.01%
49
-18
-27% -$11.8K
FTFT icon
840
Future FinTech Group
FTFT
$1.74M
$23K ﹤0.01%
+17
New +$28.5K
ACGN
841
DELISTED
Aceragen Inc
ACGN
$23K ﹤0.01%
+128
New +$29.9K
TTNP
842
DELISTED
Titan Pharmaceuticals
TTNP
$22K ﹤0.01%
+6
New +$20.1K
IMUC
843
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$22K ﹤0.01%
86,530
MUX icon
844
McEwen Inc
MUX
$1B
$21K ﹤0.01%
1,020
ATYR
845
aTyr Pharma
ATYR
$47.4M
$21K ﹤0.01%
+1,679
New +$39.8K
GPUS
846
Hyperscale Data Inc
GPUS
$52.9M
0
VLRX
847
DELISTED
VALERITAS HOLDINGS INC
VLRX
$19K ﹤0.01%
+725
New +$25.1K
CXRX
848
DELISTED
Concordia International Corp. Common Stock
CXRX
$19K ﹤0.01%
+90,000
New +$34K
DCOY
849
Decoy Therapeutics
DCOY
$2.14M
0
ANTH
850
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$17K ﹤0.01%
210,914
+150,000
+246% +$44.5K

Similar funds

Wedbush Securities's Q2 2018 Portfolio in Review

As of Q2 2018, Wedbush Securities held 932 positions worth $807M, up 5.3% from $766M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Wedbush Securities's Q2 2018 filing shows 112 new, 378 increased, 301 reduced and 51 closed positions. Its largest new stake was BayCom: 46,324 shares worth $1.15M. The largest sale was GGP Inc., an estimated $2.55M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Wedbush Securities's largest Q2 2018 buy was BayCom: 46,324 shares worth $1.15M.
  • Wedbush Securities added most to AT&T in Q2 2018, an estimated $1.34M increase.
  • Wedbush Securities's biggest Q2 2018 reduction was GGP Inc., cutting an estimated $2.55M.
  • Wedbush Securities fully exited Time Warner Inc in Q2 2018, selling an estimated $999K.
  • Wedbush Securities's ten largest holdings make up 17% of its $807M portfolio in Q2 2018.
  • Wedbush Securities opened 112 new positions and closed 51 in Q2 2018.
  • Wedbush Securities's portfolio value rose 5.3% quarter-over-quarter to $807M.

Based on Wedbush Securities's 13F filing for Q2 2018, filed 3 Aug 2018.